Injections of quinolinic acid (60, 180, and 600 nmol) in the dorsal hippocampus induced significant neurotoxicity that was evident 1 day after the injection. By day 3, pyramidal as well as granular cells were affected even at the lowest dose of quinolinic acid, an effect that persisted up to 20 days. Consistent with the histological findings, animals with bilateral injections in the dorsal hippocampus were cognitively impaired during acquisition and retention of spatial information in the water maze. A subacute treatment with (0)-nicotine (62 mmol/kg/day) delivered by subcutaneous minipumps prevented the histological and cognitive deficits induced by the bilateral quinolinic acid (60 nmol) injections. These data indicate that quinolinic acid can induce degeneration of both pyramidal as well as granule cells in the hippocampus, leading to cognitive impairments in the rat, and that activation of neuronal nicotinic acetylcholine receptors can prevent the neurodegenerative process induced by quinolinic acid. ᭧ 1998 Academic Press
Nicotinic acetylcholine receptor (nAChR) agonists can induce several pharmacological effects in rodents including hormone release, analgesia, memory facilitation and increased attention, by virtue of their specific binding to selective nAChR subtypes in the brain (Arneric, Sullivan, & Williams, 1995; Brioni, Decker, Sullivan, & Arneric, 1996; Levin, 1992) . A relatively novel finding has been the demonstration that activation of neuronal nAChRs can induce neuroprotection in different models of neuronal injury.
In vitro studies have revealed that (0)-nicotine protected striatal and cortical neurons against NMDA-induced neurotoxicity but not against kainic-induced toxicity (Akaike, Tamura, Yokaota, Shimohama, & Kimura, 1994; Marin, Maus, Desagher, Glowinski, & Premont, 1994) . This neuroprotective effect of (0)-nicotine is mimicked by ABT-418 and GTS-21, two novel cholinergic channel activators; ABT-418 reversed glutamate-induced toxicity in primary cultures of rat cortical neurons and human neuroblastoma IMR32 cells (DonnellyRoberts, Xue, Arneric, & Sullivan, 1996) , and GTS-21 prevented PC12 cell death after nerve growth factor removal (Martin, Panickar, King, Deyrup, Hunter, Wang, & Meyer, 1994) . Similarly, in vivo studies have shown that (0)-nicotine reduced the loss of tyrosine-hydroxylase immunoreactive neurons after partial hemitransection of the mesostriatal dopaminergic pathway (Jan-
